Kineticos Life Sciences

Inceptor Bio specializes in developing innovative cell therapy solutions to treat challenging cancers. They focus on enhancing immune cell performance within the tumor microenvironment using novel mechanisms. The company partners with university research programs, offering lab and manufacturing resources alongside industry expertise to efficiently advance therapies into clinical trials.

Kinvard Bio, established by Kineticos Life Sciences, is a biotechnology company dedicated to combating antimicrobial resistance. It specializes in developing a novel class of antibiotics, known as lincosamides, with differentiated properties. The company's focus is on creating both oral and intravenous formulations to treat severe and chronic drug-resistant infections, including bacterial pneumonia, complicated urinary tract infections, and nontuberculosis mycobacteria lung disease.

Clarametyx Biosciences, Inc. is a biotechnology company founded in 2020 and headquartered in Columbus, Ohio. The company focuses on developing targeted and immune-enabling biologic therapies that address persistent infections associated with biofilms, which are protective layers that shield bacteria and complicate treatment. Clarametyx has created a novel technology platform that allows for the targeting of these biofilms, thereby enhancing immune response and facilitating antibiotic intervention. One of its key products in development is CMTX-001, a humanized monoclonal antibody currently in the late preclinical stage, aimed at treating hospital-acquired pneumonia. Clarametyx Biosciences is dedicated to combating life-threatening infections and reducing antibiotic resistance through its innovative therapeutic solutions.

Experic is a contract development and manufacturing organization (CDMO) and pharmaceutical supply services provider that supports every stage of a product’s life cycle from clinical development to commercial scale. It offers process development, analytical services, clinical trial supply, packaging, and logistics technology, with capabilities across dosing and packaging formats including capsule filling, powder and pellet dosing, dry powder inhalers, autoinjectors and pen assemblies. The company coordinates global delivery of high-quality products, including expedited projects, through a modern Class A GMP facility and build-to-suit suites equipped with advanced manufacturing equipment. Experic emphasizes a hands-on, personalized approach to development projects, coordinating manufacturing, packaging, and supply chain to streamline progression from clinical trials to commercialization, backed by deep expertise and customer service.

Orthobond Corp. is a biotechnology company based in North Brunswick, New Jersey, specializing in surface modification technologies for synthetic materials to enhance their biological compatibility. Founded in 2003, the company develops innovative solutions such as self-assembled monolayers of phosphonate, which facilitate biological responses on inorganic implants without relying on biologics. Orthobond's offerings include osteoconductive surface modifications that promote tissue integration and bioresistant technologies designed to prevent infections in permanent implants. Additionally, the company has introduced AI-SAMP anti-infective technology, which targets orthopedic infections by eliminating bacteria upon contact with implant surfaces and preventing biofilm formation. Through these advancements, Orthobond aims to improve the safety and efficacy of medical devices, addressing critical challenges in infection control and tissue integration.

EnteroBiotix develops orally available microbial therapeutics derived from human gastrointestinal tract bacteria. Its focus is preventing and treating diseases by restoring gut microbiota balance.

Kincell Bio specializes in contract development and manufacturing of cell therapies. It offers expertise in process and analytical development, CMC assistance, and high-quality clinical manufacturing services, ensuring transparency, accountability, and accuracy throughout the development lifecycle.

eXmoor Pharma is a specialized consultancy focusing on cell and gene therapies (ATMPs) and biopharmaceuticals. It operates a contract development and manufacturing business, offering services such as manufacturing strategy, process development consultancy, and bioprocess engineering to help clients design projects tailored to their needs and commercial objectives.

Experic is a contract development and manufacturing organization (CDMO) and pharmaceutical supply services provider that supports every stage of a product’s life cycle from clinical development to commercial scale. It offers process development, analytical services, clinical trial supply, packaging, and logistics technology, with capabilities across dosing and packaging formats including capsule filling, powder and pellet dosing, dry powder inhalers, autoinjectors and pen assemblies. The company coordinates global delivery of high-quality products, including expedited projects, through a modern Class A GMP facility and build-to-suit suites equipped with advanced manufacturing equipment. Experic emphasizes a hands-on, personalized approach to development projects, coordinating manufacturing, packaging, and supply chain to streamline progression from clinical trials to commercialization, backed by deep expertise and customer service.

Inceptor Bio specializes in developing innovative cell therapy solutions to treat challenging cancers. They focus on enhancing immune cell performance within the tumor microenvironment using novel mechanisms. The company partners with university research programs, offering lab and manufacturing resources alongside industry expertise to efficiently advance therapies into clinical trials.

EnteroBiotix develops orally available microbial therapeutics derived from human gastrointestinal tract bacteria. Its focus is preventing and treating diseases by restoring gut microbiota balance.

Kincell Bio specializes in contract development and manufacturing of cell therapies. It offers expertise in process and analytical development, CMC assistance, and high-quality clinical manufacturing services, ensuring transparency, accountability, and accuracy throughout the development lifecycle.